Učitavanje...
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
INTRODUCTION: Natalizumab is a new treatment for relapsing-remitting multiple sclerosis. Because of limited experience of this treatment, medical professionals must be alert to possible side effects. CASE PRESENTATION: We present a 34-year-old Caucasian woman with relapsing-remitting multiple sclero...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2009
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2827173/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4076/1752-1947-3-8955 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|